Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Synthesis, and Evaluation of o-(Biphenyl-3-ylmethoxy)nitrophenyl Derivatives as PD-1/PD-L1 Inhibitors with Potent Anticancer Efficacy In Vivo
Yiqiang Ouyang, Jian Gao, Lei Zhao, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7646-7666
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

fastDRH: a webserver to predict and analyze protein–ligand complexes based on molecular docking and MM/PB(GB)SA computation
Zhe Wang, Hong Pan, Huiyong Sun, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 82
Molecular glues for protein-protein interactions: Progressing toward a new dream
Markella Konstantinidou, Michelle R. Arkin
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1064-1088
Open Access | Times Cited: 21
Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges
Sadique A. Javed, Asim Najmi, Waquar Ahsan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development
Pottayil G. Sasikumar, Murali Ramachandra
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Design, Synthesis, and Pharmacological Evaluation of Biaryl-Containing PD-1/PD-L1 Interaction Inhibitors Bearing a Unique Difluoromethyleneoxy Linkage
Zilan Song, Bo Liu, Xia Peng, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16687-16702
Open Access | Times Cited: 40
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 6
Small-molecule modulators of tumor immune microenvironment
Jing Zhang, Jia Yu, Meijing Liu, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107251-107251
Closed Access | Times Cited: 5
Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020-2024)
Qiaohong Geng, Juanjuan Xu, Cheng Du, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Development and evaluation of biphenyl-based small-molecule radiotracers for PET imaging of PD-L1 in tumor
Nan Zhang, Junyi Zhu, Xin Hu, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130187-130187
Closed Access
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
Hongyu Wu, Hong Yao, Chen He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3548-3566
Open Access | Times Cited: 23
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
Chengliang Sun, Yao Cheng, Xiaojia Liu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4446-4457
Open Access | Times Cited: 22
Design, Synthesis, and Biological Evaluation of a Small-Molecule PET Agent for Imaging PD-L1 Expression
Liang Xu, Lixia Zhang, Beibei Liang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 213-213
Open Access | Times Cited: 14
Discovery and Optimization of Novel Biphenyl Derivatives Bearing Cyclopropyl Linkage as Potent Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors
Tongfei Jing, Zhijing Zhang, Zhenghui Kang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6811-6835
Closed Access | Times Cited: 13
Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents
Jin Liu, Yao Cheng, L. Yuan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 13172-13188
Closed Access | Times Cited: 13
Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting
Claudia Cerella, Mario Dicato, Marc Diederich
Pharmacological Research (2023) Vol. 196, pp. 106914-106914
Open Access | Times Cited: 12
Progress in small-molecule inhibitors targeting PD-L1
J. Xu, Yuanfang Kong, Pengbo Zhu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 4, pp. 1161-1175
Closed Access | Times Cited: 4
Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction
Pujan Sasmal, B. Sajeev Kumar, B. R. Prashantha Kumar, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117001-117001
Closed Access | Times Cited: 18
Design, synthesis, and evaluation of PD-1/PD-L1 small-molecule inhibitors bearing a rigid indane scaffold
Shi Cai, Kaizhen Wang, Zhihao Qi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115468-115468
Closed Access | Times Cited: 11
Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2′-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors
Hua Zhang, Shijia Zhou, Jacek Plewka, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10579-10603
Closed Access | Times Cited: 11
Computational analysis of PD-L1 dimerization mechanism induced by small molecules and potential dynamical properties
Xiaole Xu, Song Luo, Xiaoyu Zhao, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130921-130921
Closed Access | Times Cited: 3
PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?
Clemens Zwergel, Rossella Fioravanti, Antonello Mai
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103435-103435
Closed Access | Times Cited: 14
Modular preparation of biphenyl triazoles via click chemistry as non-competitive hyaluronidase inhibitors
Yiman Qin, G. Li, Ling Wang, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107291-107291
Closed Access | Times Cited: 2
Advances of Biphenyl Small-Molecule Inhibitors Targeting PD-1/PD-L1 Interaction in Cancer Immunotherapy
Roufen Chen, Dandan Yuan, Junjie Ma
Future Medicinal Chemistry (2021) Vol. 14, Iss. 2, pp. 97-113
Closed Access | Times Cited: 14
Carbohydrate Strengthens the Immunotherapeutic Effect of Small-Molecule PD-L1 Inhibitors
Qian Dong, Mengya Tong, Xiaolu Yu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7179-7204
Closed Access | Times Cited: 5
Synthesis and preliminary evaluation of aminophenol derivatives as molecular glues blocking PD-1/PD-L1 interaction
Qiaohong Geng, Yanyan Dong, Jin Peng, et al.
Journal of Molecular Structure (2023) Vol. 1289, pp. 135900-135900
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top